UCB reports superiority of bimekizumab in psoriatic arthritis study
11th March 2026 Uncategorised 0
BE BOLD trial shows bimekizumab outperforms risankizumab at Week 16

More: UCB reports superiority of bimekizumab in psoriatic arthritis study
Source: News
